The clearance adds a Centiloid scale tool to GE Healthcare’s Mim software to help clinicians determine the density of amyloid ...

GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...

GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based ...

The GE HealthCare imaging tool is coming out as pharma companies release new therapies onto the market to help treat the ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

A study published Wednesday in Nature Neuroscience sheds light into how amyloid-beta and tau proteins impact brain activity ...

GE HealthCare’s MIM Software receives US FDA clearance of new Centiloid scaling tool to quantify amyloid plaque in brain imaging: Chicago Thursday, September 19, 2024, 12:00 Hrs ...

Increasingly, researchers are looking to develop blood tests that could help make Alzheimer's diagnosis faster, more accurate ...

With FDA 510(k) clearance, MIMneuro may perform positron emission tomography-based imaging analysis of amyloid plaque, GE ...

MIM Software’s Centiloid scaling tool is approved for positron emission tomography (PET)-based amyloid imaging analysis and ...